news paper icon

Analyzed News

Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys

The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Ele­vidys, after three patients died from liver failure after taking it or a similar treatment. [Source]

Publication Date:

Origin: nytimes.com

Category: Therapy and Rehabilitation

Topics: Sarepta, treatment, similar, taking, failure, liver, patients, three, Ele­vidys, therapy, shipments, Therapeutics, asked, regulator, Elevidys, Dystrophy, Muscular, Shipping, Request, Refuses

Source: https://www.nytimes.com/2025/07/18/health/fda-sarepta-elevidys-duchenne.html

Related Articles